{"id":"NCT01480180","sponsor":"Novo Nordisk A/S","briefTitle":"Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A","officialTitle":"A Multi-national Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Haemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01-30","primaryCompletion":"2018-12-10","completion":"2018-12-10","firstPosted":"2011-11-28","resultsPosted":"2020-04-20","lastUpdate":"2020-11-23"},"enrollment":186,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Haemophilia A"],"interventions":[{"type":"DRUG","name":"turoctocog alfa pegol","otherNames":["NNC 0129-0000-1003"]}],"arms":[{"label":"Prophylaxis","type":"EXPERIMENTAL"},{"label":"On-demand","type":"EXPERIMENTAL"}],"summary":"This trial is conducted globally. The aim of the trial is to evaluate the safety and efficacy, including pharmacokinetics (the exposure of the trial drug in the body) of NNC 0129-0000-1003 (N8-GP) in subjects with Haemophilia A.","primaryOutcome":{"measure":"The Incidence Rate of FVIII-inhibitors ≥0.6 BU: After Approximately 19 Months","timeFrame":"After approximately 19 months","effectByArm":[{"arm":"N8-GP 50 U/kg Prophylaxis Q4D","deltaMin":0.006,"sd":null},{"arm":"N8-GP 20-75 U/kg On-demand","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":93,"countries":["United States","Australia","Brazil","Bulgaria","Croatia","Denmark","France","Germany","Hungary","Israel","Italy","Japan","Malaysia","Netherlands","Norway","Puerto Rico","Russia","South Korea","Spain","Sweden","Switzerland","Taiwan","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["27904904","32544297"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":177},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Arthralgia","Diarrhoea"]}}